0001752724-22-155161.txt : 20220712
0001752724-22-155161.hdr.sgml : 20220712
20220712091629
ACCESSION NUMBER: 0001752724-22-155161
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 3
CONFORMED PERIOD OF REPORT: 20220430
FILED AS OF DATE: 20220712
DATE AS OF CHANGE: 20220712
EFFECTIVENESS DATE: 20220712
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXCHANGE TRADED CONCEPTS TRUST
CENTRAL INDEX KEY: 0001452937
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-22263
FILM NUMBER: 221078336
BUSINESS ADDRESS:
STREET 1: 10900 HEFNER POINTE DRIVE
STREET 2: SUITE 400
CITY: OKLAHOMA CITY
STATE: OK
ZIP: 73120
BUSINESS PHONE: 405-778-8377
MAIL ADDRESS:
STREET 1: 10900 HEFNER POINTE DRIVE
STREET 2: SUITE 400
CITY: OKLAHOMA CITY
STATE: OK
ZIP: 73120
FORMER COMPANY:
FORMER CONFORMED NAME: FAITHSHARES TRUST
DATE OF NAME CHANGE: 20090717
FORMER COMPANY:
FORMER CONFORMED NAME: FAITHSHARES INC
DATE OF NAME CHANGE: 20090225
FORMER COMPANY:
FORMER CONFORMED NAME: VERITAS FUNDS INC
DATE OF NAME CHANGE: 20081230
0001452937
S000042659
ROBO Global(R) Robotics and Automation Index ETF
C000131868
ROBO Global(R) Robotics and Automation Index ETF
ROBO
0001452937
S000065729
ROBO Global(R) Artificial Intelligence ETF
C000212574
ROBO Global(R) Artificial Intelligence ETF
THNQ
0001452937
S000065730
ROBO Global(R) Healthcare Technology and Innovation ETF
C000212575
ROBO Global(R) Healthcare Technology and Innovation ETF
HTEC
0001452937
S000068816
Nifty India Financials ETF
C000219897
Nifty India Financials ETF
INDF
N-CEN
1
primary_doc.xml
X0404
N-CEN
LIVE
0001452937
XXXXXXXX
811-22263
N-1A
S000065729
true
S000068816
true
S000042659
true
S000065730
true
EXCHANGE TRADED CONCEPTS TRUST
811-22263
0001452937
549300TXJW88BSB0KL90
10900 HEFNER POINTE DRIVE
SUITE 400
OKLAHOMA CITY
73120
US-OK
US
4057788377
SEI INVESTMENTS GLOBAL FUNDS SERVICES
1 Freedom Valley Drive
OAKS
19456
610-676-1000
Records as Administrator for Trust
BROWN BROTHERS HARRIMAN & CO.
40 Water Street
Boston
02109
617-772-1818
Records as Custodian and Transfer Agent for Trust
SEI INVESTMENTS DISTRIBUTION CO.
1 Freedom Valley Drive
OAKS
19456
610-676-1000
Records as Distributor for Trust
Exchange Traded Concepts, LLC
10900 Hefner Pointe Drive
SUITE 400
Oklahoma City
73120
1-405-778-8377
Records as Advisor for Trust
Bank of New York Mellon
240 Greenwich Street
New York
10286
1-212-495-1784
Records as Custodian and Transfer Agent for Trust
Vident Investment Advisory, LLC
300 Colonial Center Parkway
Suite 330
Roswell
30076
1-404-487-1961
Records as sub-advisor for Trust
N
N
N
N-1A
20
Y
Stuart Strauss
N/A
N
J. Garrett Stevens
N/A
Y
Linda Petrone
N/A
N
Timothy Jacoby
N/A
N
Mark Zurack
N/A
N
Matthew B. Fleischer
N/A
295 Madison Avenue
26th Floor
New York
10017
XXXXXX
Y
N
N
N
N
N
SEI INVESTMENTS DISTRIBTUION CO.
8-27897
000010690
N/A
N
N
Cohen & Company, Ltd
925
N/A
N
N
N
N
N
N
N
Nifty India Financials ETF
S000068816
5493002SQJ8SYE3VG403
N
1
0
0
Exchange-Traded Fund
N
N
-0.67
-1.44
4.212755847
4.191902786
Y
N
N
N
N/A
N/A
N/A
Rule 6c-11 (17 CFR 270.6c-11)
Rule 32a-4 (17 CFR 270.32a-4)
N
N
N
N
Exchange Traded Concepts, LLC
801-70485
000151197
549300BB5DRIKK8VVV91
N
BROWN BROTHERS HARRIMAN & CO.
084-60256
5493006KMX1VFTPYPW14
N
N
N
Pricing Direct
549300WIC0TOJ7N7GD54
N
S&P
549300U4VWNITEKO2881
N
Bloomberg
254900BF4G8VMW8GG471
N
Intercontinental Exchange, Inc.
5493000F4ZO33MV32P92
N
Thomson Reuters Corporation
549300561UZND4C7B569
CA
N
IHS Markit
549300HLPTRASHS0E726
GB
N
N
BROWN BROTHERS HARRIMAN & CO.
5493006KMX1VFTPYPW14
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
BROWN BROTHERS HARRIMAN & CO.
5493006KMX1VFTPYPW14
N
N
N
SEI Investments Global Funds Services
801-24593
SEC File Number
N
N
N
SEI Investments Distribution Co.
8-27897
000010690
N/A
0.00
BTIG LLC
008-65473
000122225
549300GTG9PL6WO3EC51
709.71000000
ITG
008-44218
000029299
549300S41SMIODVIT266
4370.39999999
EFG CAPITAL (INSTANBUL)
8-48969
000040118
N/A
466.36000000
5546.46999999
0.00
N
8094610.83999999
N
N
N
ROBO Global(R) Artificial Intelligence ETF
S000065729
549300AO11OCTHSACQ26
N
1
0
0
Exchange-Traded Fund
N
N
0.28
-0.23
0.568241753
0.558341106
Y
N
Y
N
Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
N/A
N/A
N/A
Rule 32a-4 (17 CFR 270.32a-4)
Rule 6c-11 (17 CFR 270.6c-11)
N
N
N
N
Exchange Traded Concepts LLC
801-70485
000151197
549300BB5DRIKK8VVV91
N
The Bank of New York Mellon
N/A
HPFHU0OQ28E4N0NFVK49
N
N
N
S&P
549300U4VWNITEKO2881
N
Pricing Direct
549300WIC0TOJ7N7GD54
N
Intercontinental Exchange, Inc.
5493000F4ZO33MV32P92
N
Thomson Reuters Corporation
549300561UZND4C7B569
CA
N
Bloomberg
254900BF4G8VMW8GG471
N
IHS Markit
549300HLPTRASHS0E726
GB
N
N
The Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
The Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
N
SEI Investments Global Funds Services
801-24593
SEC File Number
N
N
N
SEI Investments Distribution Co.
8-27897
000010690
N/A
0.00
SOCIETE GENERALE COWEN SECURITIES CORP.
008-40756
000023857
5493008QI0EFC5WBED75
14.03
MISCHLER FINANCIAL
8-48067
000037818
2549004IPXPSM9EJFC92
6307.90
BTIG
008-65473
000122225
549300GTG9PL6WO3EC51
551.17
MORGAN STANLEY & CO, INC
008-15869
000008209
9R7GPTSO7KV3UQJZQ078
4.44
PERSHING LLC
008-17574
000007560
ZI8Q1A8EI8LQFJNM0D94
274.44
7151.98
0.00
N
38697982.44
N
N
N
ROBO Global(R) Robotics and Automation Index ETF
S000042659
549300DWX5221AQZYJ12
N
1
0
0
Exchange-Traded Fund
N
N
0.16
-0.59
0.145543864
0.135433905
Y
N
Y
N
N
Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
Administrative fee
221223912.00000000
2770141.67000000
Rule 32a-4 (17 CFR 270.32a-4)
Rule 6c-11 (17 CFR 270.6c-11)
N
N
N
N
Exchange Traded Concepts, LLC
801-70485
000151197
549300BB5DRIKK8VVV91
N
Vident Investment Advisory, LLC
801-80534
000171004
254900XSZB691Z1A6X78
N
N
Bank of New York Mellon
085-05006
HPFHU0OQ28E4N0NFVK49
N
N
N
Pricing Direct
549300WIC0TOJ7N7GD54
N
Intercontinental Exchange, Inc.
5493000F4ZO33MV32P92
N
S&P
549300U4VWNITEKO2881
N
Bloomberg
254900BF4G8VMW8GG471
N
IHS Markit
549300HLPTRASHS0E726
GB
N
Thomson Reuters Corporation
549300561UZND4C7B569
CA
N
N
SKANDINAVISKA ENSKILDA BANKEN, STOCKHOLM
N/A
SE
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
BANK HAPOALIM B.M.
N/A
IL
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
HSBC BANK (TAIWAN) LIMITED
N/A
TW
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
CIBC MELLON TRUST COMPANY
N/A
CA
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
EUROCLEAR BANK, BRUSSELS
N/A
BE
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
THE BANK OF NEW YORK MELLON SA/NV, ASSET SERVICING, NIEDERLASSUNG FRANKFURT AM MAIN
N/A
DE
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
The Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
THE BANK OF NEW YORK MELLON SA/NV
N/A
NL
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
CREDIT SUISSE (SWITZERLAND) LTD (T2S)
N/A
CH
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
SKANDINAVISKA ENSKILDA BANKEN, HELSINKI BRANCH
N/A
FI
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
DEUTSCHE BANK-SEOUL BRANCH
N/A
KR
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
THE BANK OF NEW YORK MELLON
N/A
NL
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
HSBC SHANGHAI-HONG KONG STOCK CONNECT SPSA
N/A
HK
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
CREDIT SUISSE (SWITZERLAND) LTD
N/A
CH
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
ESES FRANCE REGISTERED
N/A
FR
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
THE BANK OF NEW YORK MELLON
N/A
FI
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
HONGKONG AND SHANGHAI BANKING CORPORATION, HONG KONG
N/A
HK
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
THE BANK OF NEW YORK MELLON
N/A
FR
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
ESES FRANCE BEARER
N/A
FR
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
THE BANK OF NEW YORK MELLON
N/A
GB
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
MUFG BANK, LTD
N/A
JP
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
SKANDINAVISKA ENSKILDA BANKEN AB, OSLO BRANCH
N/A
NO
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
THE BANK OF NEW YORK MELLON
N/A
DE
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
N
The Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
N
SEI Investments Global Funds Services
801-24593
SEC File Number
N
N
N
SEI Investments Distribution Co.
8-27897
000010690
N/A
0.00
BAML
008-69787
000283942
549300HN4UKV1E2R3U73
1068.05000000
JANE STREET EXECUTION SERVICES
8-69254
000167280
549300HXJLXCPDWAH070
40274.61999999
UBS SECURITIES
008-22651
000007654
T6FIZBDPKLYJKFCRVK44
46129.90999999
GOLDMAN SACHS & CO
008-00129
000000361
FOR8UP27PHTHYVLBNG30
76663.01000000
BTIG LLC
008-65473
000122225
549300GTG9PL6WO3EC51
123953.56000000
VIRTU FINANCIAL BD LLC
8-60815
000148390
54930088MP91YZQJT494
9819.55000000
JPM CHASE
008-35008
000000079
ZBUT11V806EZRVTWT807
9051.64000000
IMPERIAL CAPITAL
008-50397
000043744
549300I8X15KSI64Y307
44454.64000000
351414.98000000
0.00
N
1794942150.58999990
N
N
N
ROBO Global(R) Healthcare Technology and Innovation ETF
S000065730
549300DWX5221AQZYJ12
N
1
0
0
Exchange-Traded Fund
N
N
0.08
-0.37
0.188904394
0.162574942
Y
N
Y
N
Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
N/A
N/A
N/A
Rule 32a-4 (17 CFR 270.32a-4)
Rule 6c-11 (17 CFR 270.6c-11)
N
N
N
N
Exchange Traded Concepts, LLC
801-70485
000151197
549300BB5DRIKK8VVV91
N
Bank of New York Mellon
085-05006
HPFHU0OQ28E4N0NFVK49
N
N
N
IHS Markit
549300HLPTRASHS0E726
GB
N
Pricing Direct
549300WIC0TOJ7N7GD54
N
S&P
549300U4VWNITEKO2881
N
Thomson Reuters Corporation
549300561UZND4C7B569
CA
N
Bloomberg
254900BF4G8VMW8GG471
N
Intercontinental Exchange, Inc.
5493000F4ZO33MV32P92
N
N
Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
The Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
N
SEI Investments Global Funds Services
801-24593
SEC File Number
N
N
N
SEI Investments Distribution Co.
8-27897
000010690
N/A
0.00
BTIG
008-65473
000122225
549300GTG9PL6WO3EC51
37037.10000000
MISCHLER FINANCIAL
8-48067
000037818
2549004IPXPSM9EJFC92
11572.84999999
48609.95000000
0.00
N
210905988.33000001
N
N
N
Nifty India Financials ETF
S000068816
N
25000.00000000
100.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
1000.00000000
0.00000000
0.00000000
1000.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
N
ROBO Global(R) Artificial Intelligence ETF
S000065729
Y
25000.00000000
6.39948849
0.74829439
93.60051150
0.74829439
13.42815547
6.72560460
86.57184452
6.72560460
0.00000000
366.66666666
0.00000000
0.00000000
366.66666666
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
Y
ROBO Global(R) Robotics and Automation Index ETF
S000042659
Y
50000.00000000
8.85742842
1.88823156
91.14257157
1.88823156
7.30265946
2.56518037
92.69734053
2.56518037
0.00000000
900.00000000
0.00000000
0.00000000
900.00000000
0.00000000
0.00000000
851.85185185
0.00000000
0.00000000
851.85185185
0.00000000
Y
ROBO Global(R) Healthcare Technology and Innovation ETF
S000065730
Y
25000.00000000
1.50716723
1.18195732
98.49283276
1.18195732
2.11654574
2.34103897
97.88345425
2.34103897
0.00000000
471.42857142
0.00000000
0.00000000
366.66666666
0.00000000
0.00000000
412.50000000
0.00000000
0.00000000
0.00000000
0.00000000
Y
false
false
true
false
false
false
INTERNAL CONTROL RPT
2
ROBO_ICL.txt
INTERNAL CONTROL LETTER
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
To the Shareholders of ROBO Global Healthcare
Technology and Innovation ETF, ROBO Global Robotics
and Automation Index ETF, and ROBO Global
Artificial Intelligence ETF and
Board of Trustees of Exchange Traded Concepts Trust
In planning and performing our audit of the
financial statements of ROBO Global Healthcare
Technology and Innovation ETF, ROBO Global Robotics
and Automation Index ETF, and ROBO Global
Artificial Intelligence ETF (the Funds), each a
series of Exchange Traded Concepts Trust, as of and
for the year ended April 30, 2022, in accordance
with the standards of the Public Company Accounting
Oversight Board (United States) (PCAOB), we
considered the Funds internal control over financial
reporting, including controls over safeguarding
securities, as a basis for designing our auditing
procedures for the purpose of expressing our opinion
on the financial statements and to comply with the
requirements of Form N-CEN, but not for the purpose
of expressing an opinion on the effectiveness of the
Funds internal control over financial reporting.
Accordingly, we express no such opinion.
The management of the Funds is responsible for
establishing and maintaining effective internal
control over financial reporting. In fulfilling
this responsibility, estimates and judgments by
management are required to assess the expected
benefits and related costs of controls. A funds
internal control over financial reporting is a
process designed to provide reasonable assurance
regarding the reliability of financial reporting and
the preparation of financial statements for external
purposes in accordance with generally accepted
accounting principles (GAAP). A funds internal
control over financial reporting includes those
policies and procedures that (1) pertain to the
maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and
dispositions of the assets of the fund; (2) provide
reasonable assurance that transactions are recorded
as necessary to permit preparation of financial
statements in accordance with GAAP, and that
receipts and expenditures of the fund are being made
only in accordance with authorizations of management
and trustees of the fund; and (3) provide reasonable
assurance regarding prevention or timely detection
of unauthorized acquisition, use or disposition of a
funds assets that could have a material effect on
the financial statements.
Because of its inherent limitations, internal
control over financial reporting may not prevent or
detect misstatements. Also, projections of any
evaluation of effectiveness to future periods are
subject to the risk that controls may become
inadequate because of changes in conditions, or that
the degree of compliance with the policies or
procedures may deteriorate.
A deficiency in internal control over financial
reporting exists when the design or operation of a
control does not allow management or employees, in
the normal course of performing their assigned
functions, to prevent or detect misstatements on a
timely basis. A material weakness is a deficiency,
or combination of deficiencies, in internal control
over financial reporting, such that there is a
reasonable possibility that a material misstatement
of the Funds annual or interim financial statements
will not be prevented or detected on a timely basis.
Our consideration of the Funds internal control over
financial reporting was for the limited purpose
described in the first paragraph and would not
necessarily disclose all deficiencies in internal
control that might be material weaknesses under
standards established by the PCAOB. However, we
noted no deficiencies in the Funds internal control
over financial reporting and its operation,
including controls over safeguarding securities,
that we consider to be a material weakness as
defined above as of April 30, 2022.
This report is intended solely for the information
and use of management and the Board of Trustees of
the Funds and the Securities and Exchange Commission
and is not intended to be and should not be used by
anyone other than these specified parties.
COHEN & COMPANY, LTD.
Cleveland, Ohio
June 29, 2022
INTERNAL CONTROL RPT
3
INDF_ICL.txt
INTERNAL CONTROL LETTER
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
To the Shareholders of Nifty India Financials ETF
and
Board of Trustees of Exchange Traded Concepts Trust
In planning and performing our audit of the
financial statements of Nifty India Financials ETF
(the Fund), a series of Exchange Traded Concepts
Trust, as of and for the year ended April 30, 2022,
in accordance with the standards of the Public
Company Accounting Oversight Board (United States)
(PCAOB), we considered the Funds internal control
over financial reporting, including controls over
safeguarding securities, as a basis for designing
our auditing procedures for the purpose of
expressing our opinion on the financial statements
and to comply with the requirements of Form N-CEN,
but not for the purpose of expressing an opinion on
the effectiveness of the Funds internal control over
financial reporting. Accordingly, we express no
such opinion.
The management of the Fund is responsible for
establishing and maintaining effective internal
control over financial reporting. In fulfilling
this responsibility, estimates and judgments by
management are required to assess the expected
benefits and related costs of controls. A funds
internal control over financial reporting is a
process designed to provide reasonable assurance
regarding the reliability of financial reporting and
the preparation of financial statements for external
purposes in accordance with generally accepted
accounting principles (GAAP). A funds internal
control over financial reporting includes those
policies and procedures that (1) pertain to the
maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and
dispositions of the assets of the fund; (2) provide
reasonable assurance that transactions are recorded
as necessary to permit preparation of financial
statements in accordance with GAAP, and that
receipts and expenditures of the fund are being made
only in accordance with authorizations of management
and trustees of the fund; and (3) provide reasonable
assurance regarding prevention or timely detection
of unauthorized acquisition, use or disposition of a
funds assets that could have a material effect on
the financial statements.
Because of its inherent limitations, internal
control over financial reporting may not prevent or
detect misstatements. Also, projections of any
evaluation of effectiveness to future periods are
subject to the risk that controls may become
inadequate because of changes in conditions, or that
the degree of compliance with the policies or
procedures may deteriorate.
A deficiency in internal control over financial
reporting exists when the design or operation of a
control does not allow management or employees, in
the normal course of performing their assigned
functions, to prevent or detect misstatements on a
timely basis. A material weakness is a deficiency,
or combination of deficiencies, in internal control
over financial reporting, such that there is a
reasonable possibility that a material misstatement
of the Funds annual or interim financial statements
will not be prevented or detected on a timely basis.
Our consideration of the Funds internal control over
financial reporting was for the limited purpose
described in the first paragraph and would not
necessarily disclose all deficiencies in internal
control that might be material weaknesses under
standards established by the PCAOB. However, we
noted no deficiencies in the Funds internal control
over financial reporting and its operation,
including controls over safeguarding securities,
that we consider to be a material weakness as
defined above as of April 30, 2022.
This report is intended solely for the information
and use of management and the Board of Trustees of
the Fund and the Securities and Exchange Commission
and is not intended to be and should not be used by
anyone other than these specified parties.
COHEN & COMPANY, LTD.
Cleveland, Ohio
June 29, 2022